9 May 2023
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful
Notification of Stabilisation Transactions
to the Relevant Competent Authority
Deutsche Bank Aktiengesellschaft "DB" contact: Jeremy Selway, telephone +44 020 7547 5983, hereby gives notice that in relation to the offer of securities described below, it has undertaken the following stabilisation transactions on the dates listed below:
| Issuer: |
Cheplapharm Arzneimittel GmbH |
| Guarantor if any: |
CheplaFinance 2 GmbH with limited recourse If Cheplapharm Switzerland will acquire some or all of the assets subject to the Izac Acquisition, as of the Escrow Release Date, the Notes will, subject to certain agreed security principles, also be guaranteed on a senior basis by Cheplapharm Switzerland. |
| Aggregate nominal amount: |
EUR 425.000.000 |
| Description: |
EUR 425,000,000 Senior Secured Notes 7.50% due 2030 RegS ISIN: XS2618867159; 144A ISIN: XS2618869445 |
| Issue/reoffer Price: |
100 |
| Spread over benchmark: |
+523 bps |
| Trading venue on which stabilisation occurred: **Where there is more than one trading venue, ensure that the relevant competent authority of each trading venue is reported to as necessary. |
The International Stock Exchange |
| Stabilising Managers |
Deutsche Bank Aktiengesellschaft |
| Stabilisation started: |
26 April 2023 |
| Date |
Time |
Quantity |
Size |
Currency |
Price |
B/S |
| 26/04/23 |
16:00 |
1,000,000 |
1,000,000 |
EUR |
100.125 |
Buy |
| 27/04/2023 |
14:05 |
1,000,000 |
1,000,000 |
EUR |
100.375 |
Buy |
| 27/04/2023 |
14:05 |
1,000,000 |
1,000,000 |
EUR |
100.375 |
Buy |
| 27/04/2023 |
14:40 |
4,000,000 |
4,000,000 |
EUR |
100.375 |
Buy |
| 28/04/2023 |
10:28 |
2,000,000 |
2,000,000 |
EUR |
100.375 |
Buy |
| 28/04/2023 |
16:29 |
3,000,000 |
3,000,000 |
EUR |
100.625 |
Buy |
| 02/05/2023 |
08:36 |
2,000,000 |
2,000,000 |
EUR |
100.625 |
Buy |
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.